Ciclesonide HFA
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ciclesonide HFA, covering 2012-06-07 to 2012-06-07. Get the full timeline:
Most recent: Clinical Trial Update: A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older [Phase 3]